'Sympathy goes out to anyone who lost loved ones,' says AstraZeneca on Covishield row
The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases".
Source: businesstoday.in